Back to News
Market Impact: 0.3
What's Going On with Bristol Myers Squibb Stock on Friday?
Source: benzinga.com
Healthcare & BiotechCompany Fundamentals
Bristol Myers Squibb shares traded lower Friday after the company reported one patient death in a trial of an investigational CD19-directed CAR T cell therapy. The report does not provide further details on the death or the trial’s status.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
BMY-0.75
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say